A specialty pharmaceutical business that acquires, develops and markets a portfolio of mature branded medicines globally

Atnahs is a specialty pharmaceutical business, focused on acquiring mature branded medicines out of large cap and specialty pharma companies and developing its own niche medicines. Atnahs operates a portfolio of over 800 SKUs across more than 130 markets.

At a glance
Investment date
August 2019
Consumer / Health
Triton contact
Michael Thanner
Michael Thanner
Investment Advisory Professional
Company website
Press Releases